GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vext Science Inc (OTCPK:VEXTF) » Definitions » COGS-to-Revenue

VEXTF (Vext Science) COGS-to-Revenue : 0.56 (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Vext Science COGS-to-Revenue?

Vext Science's Cost of Goods Sold for the three months ended in Sep. 2024 was $5.02 Mil. Its Revenue for the three months ended in Sep. 2024 was $8.99 Mil.

Vext Science's COGS to Revenue for the three months ended in Sep. 2024 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Vext Science's Gross Margin % for the three months ended in Sep. 2024 was 44.15%.


Vext Science COGS-to-Revenue Historical Data

The historical data trend for Vext Science's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vext Science COGS-to-Revenue Chart

Vext Science Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial 0.55 0.56 0.56 0.35 0.65

Vext Science Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.78 0.84 0.82 0.56

Vext Science COGS-to-Revenue Calculation

Vext Science's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=22.774 / 34.812
=0.65

Vext Science's COGS to Revenue for the quarter that ended in Sep. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=5.019 / 8.987
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vext Science  (OTCPK:VEXTF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Vext Science's Gross Margin % for the three months ended in Sep. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 5.019 / 8.987
=44.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Vext Science COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vext Science's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Vext Science Business Description

Traded in Other Exchanges
Address
4152 N. 39th Avenue, Admin, Phoenix, AZ, USA, 85019
Vext Science Inc provides management, advisory, cultivation, and dispensary services to entities in the medical cannabis field. The company's expertise spans from cultivation through to retail operations. Its revenue sources include management fees, professional services, product sales, equipment leasing and property leasing. The Company's operations consist of a single operating segment engaged in the cultivation, manufacturing, distribution and sale of cannabis within the United States.